Home

ABOUT

Editorial

PRESS RELEASES

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR

SUBSCRIBE

Market Reports

FDA

Executives

Funding

Non Profits

Hospitals

Acquisitions

Health

Biotechnology News Magazine

HomeBiopsy

Biopsy

Breath Biopsy Panel for Respiratory Diseases Now Commercially Available Reports Owlstone Medical

The breath biomarker panel, which is now commercially available, is intended to support research to distinguish between different types of chronic inflammatory airway diseases including asthma, chronic obstructive pulmonary disease, and idiopathic pulmonary fibrosis, and to facilitate better therapeutic decision making and monitoring.

Serena Bright Industry’s 1st Contrast-Enhanced Guided Biopsy Solution Now Available in the US

Serena Bright is the industry’s first contrast-enhanced guided biopsy solution and will help empower clinicians and patients in their fight against breast cancer.

Owlstone Medical to Join EU-Funded EPHOR Consortium

The consortium aims to further elucidate the complex relationships between environment and disease by developing the concept of the ‘working-life exposome’, which takes into account all occupational and related non-occupational exposures (e.g. lifestyle) throughout the lifespan of an individual.

Owlstone Medical Partners with Thermo Fisher Scientific

The collaboration seeks to advance the application of non-invasive breath sampling to address the challenges of the early detection of disease and the precision medicine delivery of healthcare through the discovery and validation of novel biomarkers

Lung Cancer Study Uses the ANGLE Parsortix System

ANGLE reports the study is being conducted by the Hellenic Oncology Research Group (“Hellenic”) lead by the Principal Investigators, Associate Professor Athanasios Kotsakis and Professor Vassilis Georgoulias of the IASO General Hospital in Athens, Greece and is investigating both ctDNA (circulating tumor DNA, fragments of dead cancer cells) and CTCs.

Enrolment Completed for Parsortix FDA Clinical Study for Metastatic Breast Cancer

3/7/19: Four leading US cancer centers, the University of Texas MD Anderson Cancer Center, the University of Southern California Norris Cancer Center, the University of Rochester Wilmot Cancer Center, and the Northwestern University Robert H Lurie Cancer Center completed enrolment of all of the required 400 evaluable subjects.

Breath Biopsy Kits Launched by Owlstone Medical

3/28/18: Commercially available research kits extend access to Breath Biopsy technology for discovery of VOC biomarkers in early disease detection and precision medicine

By using this website you agree to accept Medical Device News Magazine Privacy Policy